HYUNDAI FEED INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 994 KRW | +8.52% |
|
-.--% | -80.70% |
| 03-29 | CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index | CI |
| 01-24 | Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis | MT |
Hyundai Feed Inc, formerly CanariaBio Inc, is a Korea-based company primarily engaged in the manufacturing and sales of livestock feeds. The Company operates through two segments. The Feed Business segment is mainly engaged in the production and sale of products such as poultry feeds, pig feeds, quail feeds, and other feeds. The Business segment is mainly engaged in research and development of immunotherapy and anti-cancer treatments. The Company sells its products in domestic and international markets.
Sector
Fishing & Farming
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -80.70% | 135M | |
| +2.96% | 10.54B | |
| -1.07% | 5.73B | |
| +18.37% | 5.18B | |
| +1.00% | 5.07B | |
| -32.55% | 2.28B | |
| -0.90% | 1.83B | |
| -28.13% | 1.05B | |
| +42.10% | 978M | |
| -26.53% | 847M |
- Stock Market
- Equities
- A016790 Stock
- News HYUNDAI FEED Inc.
- Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis
